Lineage, Inc. is the world’s largest global temperature-controlled warehouse REIT with a network of 498 strategically located facilities totaling approximately 87 million ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-0.20 · Revenue $1.37B · 3 analysts
Est. EPS $-0.18 · Revenue $1.35B · 2 analysts
Est. EPS $-0.69 · Revenue $5.39B · 5 analysts
Est. EPS $-0.15 · Revenue $1.32B · 1 analysts
$2.12 per share
$2.12 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $5.4B | +0.3% | +4.9% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-98.0M | +85.2% | +37.0% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +15.4% | -53.3% | +120.1% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +4.7% | -30.4% | +19.7% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -1.8% | +85.3% | +39.9% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $196.0M | +1533.3% | +438.2% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +3.7% | +1528.8% | +422.3% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 105.0% | +31.8% | -0.1% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 0.80x | -7.0% | -7.9% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $19.2B | +2.8% | -0.8% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -0.43 vs -0.36 | -20.8% | -0.13 vs -0.20 | +36.0% |
| Revenue Surprise | $5.4B vs $5.4B | -0.8% | $1.4B vs $1.4B | -0.3% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Marchetti Kevin Patrick | director, 10 percent owner, officer: Co-Executive Chairman | Common Stock | A | 25,000 | $39.50 |
| Aug 7, 2026 | LeMasters Robb A. | officer: Chief Financial Officer | Common Stock | A | 20,000 | $41.33 |
| Jun 9, 2026 | ARCHAMBEAU SHELLYE L | director | Common Stock | A | 4,490 | — |
| Jun 9, 2026 | Falotico Nancy Joy | director | Common Stock | A | 4,490 | — |
| Jun 9, 2026 | Turner Michael John | director | Common Stock | A | 4,490 | — |
Operator: Hello, everyone. Thank you for joining us, and welcome to the Lineage Second Quarter 2026 Earnings Conference Call. [Operator Instructions] I will now hand the conference over to Ki Bin Kim, Head of Investor Relations. Please go ahead. Ki Bin Kim: Thank you. Welcome to Lineage's discussion of the second quarter 2026 financial results. Joining me today are Greg Lehmkuhl, Lineage's President and Chief Executive Officer; and Robb LeMasters, Chief Financial Officer. Our earnings presentation, which includes supplemental financial information, can be found on our Investor Relations website at ir.onelineage.com. Following management's prepared remarks, we'll be happy to take your questions. Before we start, I would like to remind everybody that our comments today will include forward-looking statements under federal securities laws. These statements are subject to numerous risks and uncertainties as described in our filings with the SEC. These risks could cause our actual results to differ materially from those expressed in or implied by our comments. Forward-looking statements in the earnings release that we issued today, along with the comments on this call, are made only as of today and will not be updated as actual events unfold. In addition, reference will be made to certain non-GAAP financial measures. Information regarding our use of these measures and reconciliation of non-GAAP to GAAP measures can be found in our press release and supplemental package that was issued this morning. Unless otherwise noted, reported figures are rounded and comparisons of the second quarter of 2026 are to the second quarter of 2025. Now I would like to turn the call over to Greg. W. Lehmkuhl: Thanks, Ki Bin, and good morning, everyone. Let me walk through our agenda for this morning. First, I'll provide key highlights from the second quarter, then I'll share our latest views on cold storage industry dynamics. Following my remarks, I'll turn it over to Robb LeMasters, who will walk through the details of our segment performance, capital structure and outlook. I'll then return to share closing comments before we open up the line for your questions. Turning to our quarterly performance on Slide 4. We are pleased to report another quarter of better-than-expected results. Operational trends continue to show signs of stabilization, and this quarter marks another step forward in demonstrating our ability to execute on our plan and navigate the industry challenges highlighted in past calls. During the second quarter, adjusted EBITDA was approximately $320 million, ahead of both our internal expectations and consensus estimates. Total AFFO was approximately $198 million or $0.76 per share, also ahead of expectations. As a reminder, the year-over-year decline in AFFO continues to be driven primarily by the expiration of prior year interest rate hedges consistent with our 2026 guidance. On a comparable basis, excluding this impact, underlying AFFO trends are …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
W. Gregory Lehmkuhl | Chief Executive Officer, President & Director | USD 1,670,594 | Male | 1973 | Active |
Sean Vanderelzen | President of North America East | USD 1,146,377 | Male | 1972 | Active |
Jeffrey Rivera | Global Chief Operations Officer | USD 978,468 | Male | 1973 | Active |
Sudarsan Thattai | Chief Transformation Officer | USD 852,459 | Male | 1973 | Active |
Timothy Smith | Chief Commercial Officer | USD 771,406 | Male | 1965 | Active |
Robb A. LeMasters | Chief Financial Officer | USD 475,127 | Male | 1978 | Active |
Kevin Patrick Marchetti | Co-Founder & Co-Executive Chairman | — | Male | 1978 | Active |
Abigail S. Fleming | Senior Vice President & Chief Accounting Officer | — | Female | 1982 | Active |
Chris Johnson | Vice President of Technology Projects | — | — | — | Active |
Adam Forste | Co-Founder & Co-Executive Chairman | — | Male | 1978 | Active |
Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline during its second-quarter 2026 earnings call, highlighting preclinical advances in corneal disease, Type 1 diabetes and hearing loss programs while Roche and Genentech continue surgical-delivery optimization work for its lead OpRegen program.
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.
Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcript
Lineage NASDAQ: LINE reported second-quarter results that exceeded its internal expectations and consensus estimates as warehouse occupancy improved and cost-control efforts helped offset continued trade-related volume pressure.
Although the revenue and EPS for Lineage, Inc. (LINE) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
